Emmanuelle Nicolas-Virelizier

Emmanuelle Nicolas-Virelizier

UNVERIFIED PROFILE

Are you Emmanuelle Nicolas-Virelizier?   Register this Author

Register author
Emmanuelle Nicolas-Virelizier

Emmanuelle Nicolas-Virelizier

Publications by authors named "Emmanuelle Nicolas-Virelizier"

Are you Emmanuelle Nicolas-Virelizier?   Register this Author

33Publications

965Reads

25Profile Views

Performance of CT Compared with F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma.

Radiology 2020 06 14;295(3):651-661. Epub 2020 Apr 14.

From the Dept of Radiology, New York Presbyterian Hosp, Columbia Univ Medical Ctr, New York, NY (F.Z.M., L.D., A.C., L.H.S.); Dept of Radiology, Rangueil Univ Hosp, Toulouse, France (F.Z.M.); Dept of Radiology, First Affiliated Hosp of Nanjing Medical Univ, Nanjing, China (A.C.); Univ Lille, CHU Lille, EA 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France (F.M.); Dept of Hematology, Centre Henri Becquerel, Rouen, France (A.S.); Dept of Hematology, Paoli-Calmette Inst, Marseille, France (J.M.S.d.C.); Dept of Nuclear Medicine, Saint-Louis Hosp, AP-HP, Paris, France (L.V.); Dept of Hematology, Univ Hosp of Dijon, Dijon, France (O.C.); Dept of Hematology, Univ Hosp of Besançon, Besançon, France (A.C.); Dept of Hematology, Univ Hosp of Reims, Reims, France (A.D.); Dept of Hematology, Leon Berard Ctr, Lyon, France (E.N.V.); Dept of Hematology, Univ Hosp of Lyon, Lyon, France (H.G.); Dept of Hematology, Univ Hosp of Angers, Angers, France (M.P.M.M.); Dept of Hematology, Bergonie Inst, Bordeaux, France (A.S.); Dept of Hematology, Saint-Antoine Hosp, AP-HP, Paris, France (R.D.); Dept of Hematology, Univ Hosp of Bordeaux, Bordeaux, France (K.B.); Dept of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France (C.B.); Dept of Hematology, Univ Hosp of Limoges, Limoges, France (M.T.); Dept of Hematology, Cochin Hosp, AP-HP, Paris, France (B.D.F.); Centre Antoine Lacassagne, Nice, France (F.P.); Dept of Nuclear Medicine, Institut Curie, Paris, France (R.D.S.); Dept of Hematology, Univ Hosp of Rennes, Rennes, France (G.M., R.H.); INSERM, U1236, Rennes, France (G.M., R.H.); and UMR1015, Institut Gustave Roussy, Université Paris Saclay, Villejuif 94800, France (L.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2020192056DOI Listing
June 2020

CD8 T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapy.

Eur J Immunol 2020 May 10;50(5):725-735. Epub 2020 Feb 10.

CIRI - Centre International de Recherche en Infectiologie, Team « Immunology of Skin Allergy and Vaccination », Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon University, F-69007, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201948318DOI Listing
May 2020

Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.

Eur J Cancer 2017 02 22;72:12-19. Epub 2016 Dec 22.

Centre Léon Bérard, Department of Hematology, Université Claude Bernard Lyon 1, Lyon, France; Department of Hematology, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1, Pierre-Bénite, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.10.036DOI Listing
February 2017

High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation.

Int J Gynecol Cancer 2017 02;27(2):248-251

*Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy; †Centre Leon Berard, Lyon; and ‡EBMT Paris Office, Paris, France; §Universitatsklinikum Frankfurt, Frankfurt, Germany; ∥Hopital Tenon, Paris, France; ¶University Hospital Gasthuisberg, Leuven, Belgium; and #Hematology Unit, Ravenna Hospital, Ravenna; and **Ospedale di Busto Arsizio, Varese, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000882DOI Listing
February 2017

[Management of side effects of targeted therapies in renal cancer: stomatological side effects (mucositis, epistaxis)].

Bull Cancer 2011 ;98(3 Suppl):S117-26

CHU HEGP, service d'oncologie médicale, 20, rue Leblanc, 75908 Paris Cedex 15, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2011.1439DOI Listing
March 2015

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

J Clin Oncol 2014 Nov 29;32(31):3506-12. Epub 2014 Sep 29.

Carrie A. Thompson, Matthew J. Maurer, James R. Cerhan, Stephen M. Ansell, David J. Inwards, Patrick B. Johnston, William R. Macon, Ivana N. Micallef, Grzegorz S. Nowakowski, Luis F. Porrata, Thomas E. Witzig, Thomas M. Habermann, Mayo Clinic, Rochester, MN; Herve Ghesquieres, Pierre Biron, Catherine Chassagne-Clément, Thérèse Gargi, Emmanuelle Nicolas-Virelizier, Marie Peix, Catherine Sebban, Centre Leon Berard, University of Lyon, Lyon, France; George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209102PMC
November 2014

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.

J Clin Oncol 2014 Apr 18;32(10):1066-73. Epub 2014 Feb 18.

Matthew J. Maurer, Hervé Ghesquières, Thomas E. Witzig, Carrie A. Thompson, Ivana N. Micallef, William R. Macon, Paul J. Kurtin, Cristine Allmer, Susan L. Slager, Thomas M. Habermann, and James R. Cerhan, Mayo Clinic, Rochester, MN; Hervé Ghesquières and Emmanuelle Nicolas-Virelizier, Centre Léon Bérard; Hervé Ghesquières and Gilles Salles, Université Claude Bernard, Unite Mixte de Recherche (UMR), Centre National de la Recherche Scientifique 5239, Lyon; Jean-Philippe Jais, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR S 872, Necker Hospital, Assistance Publique-Hopitaux de Paris; Richard Delarue, Necker Hospital; Thierry Jo Molina, Paris Descartes University, Paris Centre University Hospital, Paris; Corinne Haioun, Henri Mondor Hospital, Université Paris-Est, Créteil; Frédéric Peyrade, Centre Antoine Lacassagne, Nice; Olivier Fitoussi, Polyclinique Bordeaux-Nord, Bordeaux; Gilles Salles, Hospices Civils de Lyon, Pierre Benite; Hervé Tilly, INSERM U918, Institute for Research and Innovation in Biomedicine, Centre Henri Becquerel, Rouen, France; Nicolas Ketterer, Lausanne Hospital, Lausanne, Switzerland; and Sergei I. Syrbu and Brian K. Link, University of Iowa College of Medicine, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.5866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965261PMC
April 2014